These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Selecting an insulin program for type 1 diabetes. Scheiner G Diabetes Self Manag; 2003; 20(5):54-6, 58. PubMed ID: 14679953 [No Abstract] [Full Text] [Related]
3. IDDM: day to day management. Samal KC; Tripathy BB J Assoc Physicians India; 1997; Suppl 1():21-9. PubMed ID: 11235630 [No Abstract] [Full Text] [Related]
5. [The "dawn" phenomenon]. Levy Mizrahi I; Recasens Gràcia A Med Clin (Barc); 1985 Oct; 85(10):409-11. PubMed ID: 3908842 [No Abstract] [Full Text] [Related]
6. [Risks and side effects of intensified insulin therapy]. Honegger R; Spinas GA Wien Med Wochenschr; 1997; 147(9):226-30. PubMed ID: 9281237 [TBL] [Abstract][Full Text] [Related]
7. Long term complications of IDDM and intensified insulin treatment. Misra A Natl Med J India; 1994; 7(4):174-5. PubMed ID: 7950951 [No Abstract] [Full Text] [Related]
8. Quantifying the impact of a short-interval interruption of insulin-pump infusion sets on glycemic excursions. Zisser H Diabetes Care; 2008 Feb; 31(2):238-9. PubMed ID: 18056889 [TBL] [Abstract][Full Text] [Related]
11. Impaired endothelial antithrombotic activity following short-term interruption of continuous subcutaneous insulin infusion in type 1 diabetic patients. Iorio A; Federici MO; Mourvaki E; Ferolla P; Piroddi M; Stabile A; Timi A; Celleno R; Benedetti MM Thromb Haemost; 2007 Sep; 98(3):635-41. PubMed ID: 17849053 [TBL] [Abstract][Full Text] [Related]
12. Circulating acylated and total ghrelin and galanin in children with insulin-treated type 1 diabetes: relationship to insulin therapy, metabolic control and pubertal development. Celi F; Bini V; Papi F; Santilli E; Ferretti A; Mencacci M; Berioli MG; De Giorgi G; Falorni A Clin Endocrinol (Oxf); 2005 Aug; 63(2):139-45. PubMed ID: 16060906 [TBL] [Abstract][Full Text] [Related]
13. Fasting and postprandial plasma glucose and peripheral insulin levels in insulin-dependent diabetes mellitus and non-insulin-dependent diabetes mellitus subjects during continuous intraperitoneal versus subcutaneous insulin delivery. Hermans MP; van Ypersele de Strihou M; Ketelslegers JM; Squifflet JP; Buysschaert M Transplant Proc; 1995 Dec; 27(6):3329-30. PubMed ID: 8539974 [No Abstract] [Full Text] [Related]
14. [Prevalence of chronic diabetes complications depending on the method of insulin therapy in children and adolescents with type 1 diabetes]. Florys B; Ołdytowska A; Głowińska B; Peczyńska J; Urban M Endokrynol Diabetol Chor Przemiany Materii Wieku Rozw; 2004; 10(1):31-9. PubMed ID: 15355737 [TBL] [Abstract][Full Text] [Related]
15. [Insulin therapy with pens and pumps]. Schwedes U Med Klin (Munich); 1996 Feb; 91 Suppl 1():16. PubMed ID: 8839106 [No Abstract] [Full Text] [Related]
16. Insulin pump therapy in youth with type 1 diabetes: a retrospective paired study. Nimri R; Weintrob N; Benzaquen H; Ofan R; Fayman G; Phillip M Pediatrics; 2006 Jun; 117(6):2126-31. PubMed ID: 16740856 [TBL] [Abstract][Full Text] [Related]
18. An outpatient technique for continuous subcutaneous insulin infusion in adolescents and young adults with IDDM. Strickland AL; Strickland J J S C Med Assoc; 2000 Sep; 96(9):386-9. PubMed ID: 11043015 [No Abstract] [Full Text] [Related]
19. [Insulin pump in the treatment of adult age diabetes]. Sane T; Tulokas T; Nikkanen P; Heikkilä P; Huttunen E; Niskanen L Duodecim; 2005; 121(8):839-45. PubMed ID: 15931827 [No Abstract] [Full Text] [Related]
20. A flexible option for adolescents with diabetes. Insulin pump therapy. Boland E Adv Nurse Pract; 1998 Feb; 6(2):38-44. PubMed ID: 9555281 [No Abstract] [Full Text] [Related] [Next] [New Search]